Search
Close this search box.
Search
Subscriber Log In
Webinar | On demand

Orphan Drugs: Are They Losing Their Sparkle?

For ten years, orphan drugs have doubled their market share in global prescription drug sales, surpassing non-orphan drugs. However, their once bright gloss is beginning to dull, and their growth advantage is diminishing. Sign up for our webinar to discover the reasons behind this shift and what the future may hold.

Watch the webinar.








What to Expect

Get expert insights on:

  • Major players in the field
  • Exciting therapy areas
  • Technologies primed to drive growth
  • Rare diseases’ significance for big pharma
  • What’s piquing investors’ interest?
  • The impact of new legislation on R&D pipelines

Watch our to discover the reasons behind this shift and what the future may hold.

Melanie Senior

Author, Orphan Drug Report

Stephanie Léouzon

Managing Director, Biopharma Healthcare, Stifel

Puru Gaur

Senior Commercial Analyst, Evaluate